Document is current

Article History

Received: 6 June 2017

Accepted: 27 December 2017

First Online: 21 February 2018

Ethics approval and consent to participate

: The protocol was approved by our IRB (Comité d’Evaluation de l’Ethique des Projets de Recherche Biomédicale Paris Nord, IRB 00006477). All included patients were informed about the study, and written informed consent was obtained from all participants. If the patient was unable to be informed, the next of kin was informed and provided consent for the patient to participate.

: Not applicable.

: Etienne Gayat received a research grant from Sphingotec, Deltex Medical, and Retia Medical, and consultancy fees from Magnisense, Roche Diagnostics, and Adrenomed. Alexandre Mebazaa received speaker's honoraria from Abbott, Novartis, Orion, Roche, and Servier, and fees as a member of the advisory board and/or Steering Committee from Cardiorentis, Adrenomed, MyCartis, Neurotronik, and Sphingotec. All other co-authors have no competing interests related to the present manuscript.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.